Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.

MLA

Tada, H., et al. “Systemic IFN-Beta Gene Therapy Results in Long-Term Survival in Mice with Established Colorectal Liver Metastases.” The Journal of Clinical Investigation, vol. 108, no. 1, July 2001, pp. 83–95. EBSCOhost, https://doi.org/10.1172/JCI9841.

APA

Tada, H., Maron, D. J., Choi, E. A., Barsoum, J., Lei, H., Xie, Q., Liu, W., Ellis, L., Moscioni, A. D., Tazelaar, J., Fawell, S., Qin, X., Propert, K. J., Davis, A., Fraker, D. L., Wilson, J. M., & Spitz, F. R. (2001). Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases. The Journal of Clinical Investigation, 108(1), 83–95. https://doi.org/10.1172/JCI9841

Chicago

Tada, H, D J Maron, E A Choi, J Barsoum, H Lei, Q Xie, W Liu, et al. 2001. “Systemic IFN-Beta Gene Therapy Results in Long-Term Survival in Mice with Established Colorectal Liver Metastases.” The Journal of Clinical Investigation 108 (1): 83–95. doi:10.1172/JCI9841.